Skip to main content
. Author manuscript; available in PMC: 2010 Oct 6.
Published in final edited form as: Mol Cancer Ther. 2009 Oct 6;8(10):2926–2936. doi: 10.1158/1535-7163.MCT-08-1223

Table 1.

List of parameter values

Parameter Value Units Source
r1 1.2924 per day [16]
C1 0.1 Oxygen concentration [16]
r2 0.001 per Tumor cell density per day [16]
σ 1.0029 dimensionless [16]
C2 0.054 Oxygen concentration [16]
Cm 0.2 Oxygen concentration [16]
k 16.0 # Microvessels per mm3 1
μa 12.8810 # HDMECs per pg of Da per day [11]2
μl 806.9190 # HDMECs per pg of Cl per day [11]2
ad 3.8780×10−6 per day [11], [21]3
bd 1.7329 per Bad concentration [11], [21]3
α1 30.0 # HDMECs per Microvessel [16]
M0 17×103 # HDMECs per mm3 [16]
α2 0.2984 # Microvessels per pg of Da per day [22]2
α3 6.5757 # Microvessels per pg of Cl per day [22]2
η1a
0.2250 pg VEGF per pg Ra [16]
η2a
0.1837 pg VEGF per pg Ca [16]
η3a
0.8163 pg Ra per pg Ca [16]
η4a
0.4494 pg Ra per pg Da [16]
η5a
1.2250 pg Ca per pg Ra [16]
η6a
0.5506 pg Ca per pg Da [16]
η7a
2.2250 pg Da per pg Ra [16]
λa 15.5958 per day [16]
r3 0.1507 pg VEGF per Tumor cell per day [12]4
kf1a
1.6232 per VEGF concentration per day [16]
kr1a
49.3025 per day [16]
kf2a
162.32 per Ca concentration per day [16]
kr2a
0.493025 per day [16]
kpa
16.0 per day [16]
Vchar 55.0 # Microvessels per mm3 [16]
V0 2.0 # Microvessels per mm3 [16]
1.0 # Microvessels per mm3 [16]
kfl
6.7587 per CXCL8 concentration per day [16]
krl
43.2557 per day [16]
kpl
24.0 per day [16]
η1l
0.1311 pg CXCL8 per pg Rl [16]
η2l
0.1159 pg CXCL8 per pg Cl [16]
η3l
0.8841 pg Rl per pg Cl [16]
η4l
1.1311 pg Cl per pg Rl [16]
λl 15.5958 per day [16]
βm 8.1139×10−4 pg of CXCL8 per HDMEC per day [11] [16]2,5
ap 6.9620×10−4 pg of CXCL8 per HDMEC per day [11] [16]2,5
bp 1.6185 per Bcl-2 concentration [11] [16]2,5
α4 0.24845 # Microvessels per HDMEC [16]
kfb
4 per Bad concentration per day 1
krb
8.832 per day [3]
kfi
40 per BL193 concentration per day [3]6
kri
2.56 per day [3]6
βa 40 fg of Bcl-2 per pg Da [12]
Di 3.4650 per day 1
1

In the absence of experimental data, biologically realistic values for these parameters were chosen so that the solution profiles best fit experimental observations.

2

The parameters associated with CXCL8 production, and CXCL8 and VEGF effect on HDMEC proliferation, and microvessel formation were estimated using least squares fits of experimental data in [11, 22].

3

We know that the normal death rate of HDMECs is 0.12 per day [21]. Further, in the presence of 50 ng per ml VEGF, Bcl-2 is up-regulated 3.1 fold, and consequently the level of Bad falls by a factor of 0.77. We assume a very low HDMEC death rate corresponding to this low level of Bad. From these two observations, the constants ad and bd may be determined.

4

Keeping all other parameter values fixed, VEGF production rate by tumor cells was determined by fitting the microvessel density after 21 days with that observed experimentally in a (control) tumor that was allowed to grow without the application of any anti-cancer therapy [12].

5

A relation between the constants βm, ap and bp may be found by observing that at constitutive Bcl-2 levels, the production rate of CXCL8 is 0.0358 pg of CXCL8 per HDMEC per day [16]. Note that at constitutive levels of Bcl-2 and Bad, the cell death rate is taken to be 0.12 per day [21] and HDMEC CXCL8 production rate is fit to experiments in [12]

6

It was assumed that rate of forward reaction of BL193 with Bcl-2 was higher than that of Bad binding to Bcl-2, due to the much smaller size of BL193.